Clinical Trial Update: Vancomycin for Primary Sclerosing Cholangitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating vancomycin for primary sclerosing cholangitis has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Elizabeth Carey | Conditions: Primary Sclerosing Cholangitis | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2026-04-22